|
US5244668A
|
|
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
US5139790A
|
|
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
WO9111135A1
|
|
Cutaneous therapeutic devices
|
|
US4980150A
|
|
Chlorhexidine complex
|
|
US5082655A
|
|
Pharmaceutical composition for drugs subject to supercooling
|
|
US5004601A
|
|
Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
|
|
US5135752A
|
|
Buccal dosage form
|
|
EP0286581A1
|
|
Buccal administration of estrogens
|
|
US4832955A
|
|
Controlled release potassium chloride composition
|
|
US4764378A
|
|
Buccal drug dosage form
|
|
AU5068985A
|
|
Dentifrice containing alginate calcium chelating agent
|
|
US4629621A
|
|
Erodible matrix for sustained release bioactive composition
|
